Stock Movers: Sarepta Soars on FDA Reversal, UPS Falls on Guidance Uncertainty, Whirlpool Drops on Profit Outlook

Sarepta Therapeutics Stock Surge

• 🚀 Sarepta (SRPT) shares experienced a significant spike, up approximately 25%, following the FDA's decision to reverse its prior recommendation.
• 💡 The FDA now recommends that patients who can walk can once again receive Sarepta's gene therapy, Elevidys.
• ⚠️ This reversal comes after an initial FDA request for the company to pause shipments due to three deaths linked to the therapy, which had caused a massive sell-off.
• 📉 Despite the recent surge, Sarepta's stock is still down over 80% year-to-date, indicating ongoing challenges.

UPS Faces Challenges and Declines

• 📉 UPS shares fell nearly 10% on the day and are down 24% year-to-date.
• 📊 The parcel carrier declined to provide full-year revenue or operating profit guidance, citing macroeconomic uncertainty.
• 🛠️ This guidance uncertainty highlights ongoing challenges for UPS's network reconfiguration efforts, including headcount reductions and facility consolidations.
• 🛒 CEO cited consumer trading down due to tariffs and a struggle to recapture pandemic-era shipping volumes as contributing factors.

Whirlpool's Profit Outlook Slashed

• 📉 Whirlpool (WHR) shares tumbled 11% after the company significantly slashed its 2025 profit outlook.
• 🇺🇸 The expected boost from manufacturing the majority of its appliances in the US (around 80%) has not yet materialized as anticipated.
• 📈 Increased promotions by rival Asian appliance makers have led to a slight loss in market share for Whirlpool.
• 📦 Anticipation of tariffs has resulted in a historic oversupply in North America due to increased exports from Asian manufacturers.